345 related articles for article (PubMed ID: 38673949)
21. Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway.
Liu J; Qu L; Meng L; Shou C
J Exp Clin Cancer Res; 2019 Aug; 38(1):370. PubMed ID: 31438997
[TBL] [Abstract][Full Text] [Related]
22. Chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) receptor 2 autocrine loop contributes to cellular proliferation, migration and apoptosis in cervical cancer.
Sun J; Yuan J
Bioengineered; 2022 Mar; 13(3):7579-7591. PubMed ID: 35264061
[TBL] [Abstract][Full Text] [Related]
23. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
[TBL] [Abstract][Full Text] [Related]
24. Endostatin inhibits the tumorigenesis of hemangioendothelioma via downregulation of CXCL1.
Guo L; Song N; He T; Qi F; Zheng S; Xu XG; Fu Y; Chen HD; Luo Y
Mol Carcinog; 2015 Nov; 54(11):1340-53. PubMed ID: 25175281
[TBL] [Abstract][Full Text] [Related]
25. Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL1.
Liu CH; Jing XN; Liu XL; Qin SY; Liu MW; Hou CH
J Ovarian Res; 2020 Aug; 13(1):92. PubMed ID: 32782028
[TBL] [Abstract][Full Text] [Related]
26. Elevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200a.
Cui X; Li Z; Gao J; Gao PJ; Ni YB; Zhu JY
Oncotarget; 2016 Oct; 7(40):65052-65066. PubMed ID: 27542259
[TBL] [Abstract][Full Text] [Related]
27. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma.
Zhang H; Yue J; Jiang Z; Zhou R; Xie R; Xu Y; Wu S
Cell Death Dis; 2017 May; 8(5):e2790. PubMed ID: 28518141
[TBL] [Abstract][Full Text] [Related]
28. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
Wei LY; Lee JJ; Yeh CY; Yang CJ; Kok SH; Ko JY; Tsai FC; Chia JS
Oral Oncol; 2019 Jan; 88():115-123. PubMed ID: 30616781
[TBL] [Abstract][Full Text] [Related]
29. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin β1/FAK/AKT signaling.
Wang Z; Wang Z; Li G; Wu H; Sun K; Chen J; Feng Y; Chen C; Cai S; Xu J; He Y
Cancer Lett; 2017 Jan; 385():28-38. PubMed ID: 27832972
[TBL] [Abstract][Full Text] [Related]
30. TNF-α induces CXCL1 chemokine expression and release in human vascular endothelial cells in vitro via two distinct signaling pathways.
Lo HM; Lai TH; Li CH; Wu WB
Acta Pharmacol Sin; 2014 Mar; 35(3):339-50. PubMed ID: 24487964
[TBL] [Abstract][Full Text] [Related]
31. Baohuoside i suppresses breast cancer metastasis by downregulating the tumor-associated macrophages/C-X-C motif chemokine ligand 1 pathway.
Wang S; Wang N; Huang X; Yang B; Zheng Y; Zhang J; Wang X; Lin Y; Wang Z
Phytomedicine; 2020 Nov; 78():153331. PubMed ID: 32911383
[TBL] [Abstract][Full Text] [Related]
32. Biological function of C-X-C Motif Chemokine Ligand 1 gene (CXCL1) in ovarian malignant tumors.
Li Z; Huang N; Zhang W; Li L
Hum Exp Toxicol; 2023; 42():9603271231203392. PubMed ID: 37787042
[TBL] [Abstract][Full Text] [Related]
33. miR141-CXCL1-CXCR2 signaling-induced Treg recruitment regulates metastases and survival of non-small cell lung cancer.
Lv M; Xu Y; Tang R; Ren J; Shen S; Chen Y; Liu B; Hou Y; Wang T
Mol Cancer Ther; 2014 Dec; 13(12):3152-62. PubMed ID: 25349304
[TBL] [Abstract][Full Text] [Related]
34. Keratinocyte chemoattractant (KC)/human growth-regulated oncogene (GRO) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells.
Son DS; Parl AK; Rice VM; Khabele D
Cancer Biol Ther; 2007 Aug; 6(8):1302-12. PubMed ID: 17712227
[TBL] [Abstract][Full Text] [Related]
35. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
Morein D; Erlichman N; Ben-Baruch A
Front Immunol; 2020; 11():952. PubMed ID: 32582148
[TBL] [Abstract][Full Text] [Related]
36. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression.
Luan J; Shattuck-Brandt R; Haghnegahdar H; Owen JD; Strieter R; Burdick M; Nirodi C; Beauchamp D; Johnson KN; Richmond A
J Leukoc Biol; 1997 Nov; 62(5):588-97. PubMed ID: 9365113
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma.
Kasashima H; Yashiro M; Nakamae H; Masuda G; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Nakane T; Hino M; Hirakawa K; Ohira M
PLoS One; 2017; 12(6):e0178635. PubMed ID: 28575019
[TBL] [Abstract][Full Text] [Related]
38. CXCL1 regulation in human pulmonary epithelial cells by tumor necrosis factor.
Shieh JM; Tsai YJ; Tsou CJ; Wu WB
Cell Physiol Biochem; 2014; 34(4):1373-84. PubMed ID: 25301363
[TBL] [Abstract][Full Text] [Related]
39. CXCL1 stimulates decidual angiogenesis via the VEGF-A pathway during the first trimester of pregnancy.
Ma C; Liu G; Liu W; Xu W; Li H; Piao S; Sui Y; Feng W
Mol Cell Biochem; 2021 Aug; 476(8):2989-2998. PubMed ID: 33770315
[TBL] [Abstract][Full Text] [Related]
40. Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils.
Yuan M; Zhu H; Xu J; Zheng Y; Cao X; Liu Q
J Immunol Res; 2016; 2016():6530410. PubMed ID: 27446967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
